UKAD 2014 BWLA vs Vasyl Kruk

Facts
The British Weightlifting Association charged Vasyl Kruk, the "Athlete", for a violation of the Anti-Doping rules. On February 24, 2014, the Athlete provided an out-of-competition sample for doping control purposes. The analysis of the sample showed the presence of the metabolites of drostanolone, nandrolone and metandienone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.

History
A most important feature of this case is that the Athlete has previously been found guilty of an Anti-Doping Rule Violation (“the First ADRV”) for which the Athlete received a two year period of Ineligibility beginning on May 26, 2012 and ending at midnight on 25 May 2014. He didn't attend the hearing and confirmed the use of steroids in period between Feb 2014 and May 2014 during his ban period. The genuine reason for it was not to cheat on competition but only bring fitness back. In this response the Athlete was alluding to his lack of fitness arising out of the period of Ineligibility imposed on the Athlete as a result of the First ADRV. It contains a frank admission that he was taking steroids during the period of Ineligibility.

Decision
The sanction is a period of Ineligibility of eight years commencing from 9 am (BST) 25 May 2014 and ending at 9 am (BST) 25 May 2022.

Costs
Each party will bear their own costs of these proceedings.

Appeal
No later than 21 days from the date of receipt of this decision.

Original document

Parameters

Legal Source
National Decisions
Date
11 August 2014
Arbitrator
Casement, David
Douglas, Kitrina
Murdock, Colin
Original Source
UK Anti-Doping (UKAD)
Country
Ukraine
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Second violation
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
British Weight Lifting Association (BWLA)
UK Anti-Doping (UKAD)
Doping classes
S1. Anabolic Agents
Substances
Drostanolone
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Nandrolone (19-nortestosterone)
Document type
Pdf file
Date generated
2 September 2014
Date of last modification
3 November 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin